Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)

NCT ID: NCT07185828

Last Updated: 2025-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

8286 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-15

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this campaign is to reduce unnecessary visits to a Geisinger emergency department (ED). In this campaign, patients will be assigned to receive or not receive outreach following ED discharge with a low-acuity visit designation. Outreach will occur via a text message the day after discharge from the ED as well as information added to the patient's after visit summary (AVS). Depending on the assigned condition, it will include calls to see their primary care provider (PCP) or use an Intelligent Triage tool. The study will assess whether ED use within the following 120 days differs across patients in different outreach conditions (current standard practice vs contact your PCP vs use Intelligent Triage). It will also examine whether patients follow through on the message-specific calls to action differently across conditions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Emergency Service, Hospital Behavior Change Interventions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Patients will be aware of their own messages but not of messages sent to other patients or in other arms.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

This arm will receive no intervention outside of usual care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Contact your PCP

Intervention content emphasizes contacting a primary care provider (content will vary slightly based on whether the patient has a Geisinger PCP)

Group Type EXPERIMENTAL

Contact your PCP

Intervention Type BEHAVIORAL

Text messages will be sent and discharge paperwork will be modified to encourage contacting a primary care provider.

Use Intelligent Triage

Intervention content emphasizes using Intelligent Triage to assess symptoms.

Group Type EXPERIMENTAL

Use Intelligent Triage

Intervention Type BEHAVIORAL

Text messages will be sent and discharge paperwork will be modified to encourage using Intelligent Triage.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Contact your PCP

Text messages will be sent and discharge paperwork will be modified to encourage contacting a primary care provider.

Intervention Type BEHAVIORAL

Use Intelligent Triage

Text messages will be sent and discharge paperwork will be modified to encourage using Intelligent Triage.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \>= 18 years of age
* Geisinger ED visit rated as low acuity (L4 or L5)
* Discharged from Geisinger ED in past 24 hours

Exclusion Criteria

* Cannot be contacted via the communication modality being used in the study (i.e., SMS), due to insufficient/missing contact information in the EHR or because the patient opted out
* Admitted to hospital
* Already included in intervention in past 365 days
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Geisinger Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amir Goren

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amir Goren, PhD

Role: PRINCIPAL_INVESTIGATOR

Geisinger Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Geisinger

Danville, Pennsylvania, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amir Goren, PhD

Role: CONTACT

570-214-4395

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Amir Goren, PhD

Role: primary

570-214-4395

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-0183-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Alert Burden When Monitoring Patients at Home
NCT07096648 ACTIVE_NOT_RECRUITING
Community Paramedicine at Home
NCT02835989 COMPLETED NA